These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32482088)

  • 1. Risk Profiles in Heart Failure: Baseline, Residual, Worsening, and Advanced Heart Failure Risk.
    Greene SJ; Fonarow GC; Butler J
    Circ Heart Fail; 2020 Jun; 13(6):e007132. PubMed ID: 32482088
    [No Abstract]   [Full Text] [Related]  

  • 2. Who Would Be Branded With Failure?
    Stevenson LW
    Circulation; 2017 Oct; 136(15):1359-1361. PubMed ID: 28993370
    [No Abstract]   [Full Text] [Related]  

  • 3. Low systolic blood pressure for predicting all-cause mortality in patients hospitalised with heart failure: a systematic review and meta-analysis.
    Zhang Y; Wang C; Zhang J; Zhang H; Yin Z; Chen Y; Xie Q
    Eur J Prev Cardiol; 2019 Mar; 26(4):439-443. PubMed ID: 29939079
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishing prognosis in heart failure: a multimarker approach.
    Ketchum ES; Levy WC
    Prog Cardiovasc Dis; 2011; 54(2):86-96. PubMed ID: 21875508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalizability and Implications of the H
    Segar MW; Patel KV; Berry JD; Grodin JL; Pandey A
    Circulation; 2019 Apr; 139(15):1851-1853. PubMed ID: 30958721
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of "Failure": Is It a Failure of Prevention?
    Nambi V; Deswal A; Ballantyne CM
    Circulation; 2018 Jan; 137(2):106-108. PubMed ID: 29311345
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic value of six-minute walk distance in patients with heart failure: A meta-analysis.
    Fan Y; Gu X; Zhang H
    Eur J Prev Cardiol; 2019 Apr; 26(6):664-667. PubMed ID: 30160522
    [No Abstract]   [Full Text] [Related]  

  • 8. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging.
    Olivotto I; Cecchi F; Poggesi C; Yacoub MH
    Circ Heart Fail; 2012 Jul; 5(4):535-46. PubMed ID: 22811549
    [No Abstract]   [Full Text] [Related]  

  • 9. Implications of Using Different Definitions on Outcomes in Worsening Heart Failure.
    Kelly JP; Cooper LB; Gallup D; Anstrom KJ; Chen HH; Redfield MM; O'Connor CM; Mentz RJ; Hernanadez AF; Felker GM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation.
    Upshaw JN; Konstam MA; Klaveren Dv; Noubary F; Huggins GS; Kent DM
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27514751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced heart failure: a call to action.
    Russell SD; Miller LW; Pagani FD
    Congest Heart Fail; 2008; 14(6):316-21. PubMed ID: 19076855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ
    J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of low body temperature and poor outcomes in patients admitted with worsening heart failure: a substudy of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial.
    Payvar S; Spertus JA; Miller AB; Casscells SW; Pang PS; Zannad F; Swedberg K; Maggioni AP; Reid KJ; Gheorghiade M;
    Eur J Heart Fail; 2013 Dec; 15(12):1382-9. PubMed ID: 23858000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward.
    Eapen ZJ; Tang WH; Felker GM; Hernandez AF; Mahaffey KW; Lincoff AM; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):594-600. PubMed ID: 22811505
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee.
    Gorodeski EZ; Chu EC; Chow CH; Levy WC; Hsich E; Starling RC
    Circ Heart Fail; 2010 Nov; 3(6):706-14. PubMed ID: 20798278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction.
    Pavlović A; Polovina M; Ristić A; Seferović JP; Veljić I; Simeunović D; Milinković I; Krljanac G; Ašanin M; Oštrić-Pavlović I; Seferović PM
    Eur J Prev Cardiol; 2019 Jan; 26(1):72-82. PubMed ID: 30335505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials.
    Ibrahim NE; Gaggin HK; Konstam MA; Januzzi JL
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27582282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Hemodynamics and Response to Contrast Media During Diagnostic Cardiac Catheterization Predict Adverse Events in Heart Failure Patients.
    Denardo SJ; Vock DM; Schmalfuss CM; Young GD; Tcheng JE; O'Connor CM
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27382090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Related Differences in Heart Failure With Preserved Ejection Fraction.
    Dewan P; Rørth R; Raparelli V; Campbell RT; Shen L; Jhund PS; Petrie MC; Anand IS; Carson PE; Desai AS; Granger CB; Køber L; Komajda M; McKelvie RS; O'Meara E; Pfeffer MA; Pitt B; Solomon SD; Swedberg K; Zile MR; McMurray JJV
    Circ Heart Fail; 2019 Dec; 12(12):e006539. PubMed ID: 31813280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New guidelines, new recommendations! But what is really new? A pragmatic interpretation of the 2016 European guidelines for the management of chronic heart failure.
    de Groote P; Cohen A; Juillière Y; Damy T
    Arch Cardiovasc Dis; 2017 Jan; 110(1):1-6. PubMed ID: 28082242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.